On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The 11 worst fast food restaurants in America
- I hate Ayn Rand — but here's why my fellow conservatives love her
- Why Peter Capaldi has a bigger challenge than any Doctor Who in history
- Dean Koontz's 5 favorite books
- The weird obsession that's ruining the GOP
- 7 things the world's happiest people do every day
- Here's the schedule very successful people follow every day
- 7 grammar rules you really should pay attention to
- Why are so many parents being arrested?
- 10 things you need to know today: July 23, 2014
Subscribe to the Week